Skip to main content

AACE Annual Meeting attendees Claim CME on the event website


Together, We Are AACE



We are a global, inclusive community of endocrine-focused clinical members, affiliates and partners from every walk of professional life. We promote both formal and informal knowledge-sharing through our publications and education- and communication-focused programs. We pride ourselves in offering a uniquely personal experience that gives every member of our community a voice. Learn More

Our mission is elevating the practice of clinical endocrinology to improve global health.Learn More

We are the organization focused on endocrinology, diabetes, and metabolism that is most:

  • Recognized worldwide for its clinical leadership

  • Valued by clinical endocrinologists and other healthcare professionals

  • Trusted by patients

  • Respected by healthcare decision-makers and the public

Learn More


  • 2022 Meetings Update from CEO Paul Markowski

    After over a year of producing virtual events during an uncertain time, we are planning for a potential return to in-person events that brings both excitement and new opportunities. As a valued member of our AACE Community, I would like to be transparent with you and share how we are planning a return to in-person conferences in 2022.

    AACE 2022 Events
  • AACE Position Statement: Coronavirus (COVID-19) Vaccine and the Endocrine Community

    The COVID-19 pandemic entered a new promising phase when the first vaccines for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection became available in late 2020. We at AACE have recommendations for both endocrine patients and care providers.

    covid vaccine
  • Medicare Payment Rules

    On November 2, 2021, the U. S. Department of Health and Human Services Centers for Medicare and Medicaid Services released several final Calendar Year 2022 payment rules. Learn how these rules cover physician fee schedule, hospital outpatient and ambulatory surgical centers, and more.

    Medicare Payment Rules
  • Federal Policy Update - Nov. 2021

    On November 19th, the U.S. House of Representatives passed H.R. 5376, the “Build Back Better Act”. Learn about the new federal policy updates and how it will support the major health care provisions in H.R. 5376.

    Federal Policy Update - Nov. 2021
  • Volunteer Now to Help Update Our Obesity Guidelines

    We're seeking volunteers to update the 2016 Clinical Practice Guidelines for the Medical Care of Patients with Obesity. Volunteer now!

    raising hand to volunteer
  • Federal Policy Update - December 2021 - January 2022

    On December 3, 2021, President Biden signed the "Further Extending Government Funding Act". Public Law 117-70 funds the Federal government through February 18, 2022. It is likely Congress will again consolidate all the bills into one large appropriations bill. The big question is whether Congress can achieve an agreement on full year appropriations or simply pass another continuing resolution.

    Federal Policy Update - Dec. 2021 - Jan. 2022
  • The Outlook For Telehealth Post COVID-19 Pandemic

    The Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 [Public Law 116-123] authorized the Secretary of Health and Human Services (HHS) to waive statutory requirements with respect to telehealth services under Medicare for the duration of the COVID-19 Public Health Emergency.

  • President Update to AACE Community – January 2022

    AACE leadership spent the last year developing our 2022-2025 strategic plan, and one of our three focus areas is patient and public awareness. AACE President Dr. Felice Caldarella shares how we are further expanding and updating our patient and public resources by featuring “AACE Patient Journeys”, along with other new developments including our involvement in helping to obtain Congressional approval for the National Clinical Care Commission (NCCC) recommendations on diabetes care, and more.

    President Update to AACE Community – January 2022
  • AACE 2021 Election Results

    Congratulations to the newly elected Officers and Board members.

    together aace
  • Warning: Recent Uptick in F.A.C.E. Scams

    We have been notified of several fellowship and medical board scams that are targeting physicians by offering a medical certification and/or endocrinology fellowship designation (FACE) from a medical association for a fee.

  • Announcing our 2021 Awards, MACE and FACE recipients

    Congratulations to our 2021 Awards, MACE and FACE recipients. All recipients will be honored during our 2021 Annual Meeting.

    we are aace
  • The Health Care Workforce Shortage Issue In Congress

    The COVID-19 pandemic revealed to Federal public policymakers and the general public the need for more health care providers. More importantly, there was a greater realization of a shortage in underserved areas, particularly in certain urban, rural, and Native American settings. Learn how congress is solving the crisis in the health care workforce.

    The Health Care Workforce Shortage Issue In Congress
  • Federal Policy Update - July 2021

    In June the U.S. Supreme Court came to the end of its term. Meanwhile, Congress has begun the budget/appropriations process. Learn about the latest federal policy updates and how it can impact the future of health care.

    Federal Policy Update
  • Federal Policy Update - May 2022

    In this update on federal policy in health care, read about the rules and other items that are under OIRA review, the recent pharmacy benefit managers Congressional hearing, and more.

    Federal Policy Update
  • Calendar Year (CY) 2022 Medicare Physician Fee Schedule Proposed Rule

    On July 13, 2021, the Centers for Medicare and Medicaid Services (CMS) posted the proposed rule for the 2022 Physician Fee Schedule (PFS) and other Medicare Part B issues. Learn how the results can bring better accessibility, quality, affordability, empowerment, and innovation.

    2022 Medicare Physician Fee Schedule Proposed Rule
  • 2021 FACE Application Period is Open Through November 2

    The FACE application period is open until November 2, 2020. Applications will only be accepted online, and eligible candidates must meet the criteria set forth by the FACE Application Committee.

  • Federal Policy Update

    On May 25, the Senate confirmed Chiquita Brooks-LaSure to be the Centers for Medicare and Medicaid Services Administrator by a vote of 55-44. She was sworn in two days later. In her first interview, Brooks-LaSure stated that her top priorities will be to expand health insurance coverage and address health disparities.

    Federal Policy Update
  • Presenting – A directory of endocrine prescription affordability programs

    Presenting – A directory of prescription affordability programs and resources for your endocrine patients to help them acquire the medications they need at reduced out-of-pocket costs.

  • In Memoriam: Alan J. Garber, MD, PhD, MACE

    It is with great sadness that I share the news of Dr. Alan Garber’s passing yesterday on April 9, 2020. Dr. Garber was a Charter Member of AACE, as well as a Past President of both AACE and ACE.

  • AACE Position Statement: Coronavirus (COVID-19) and People with Thyroid Disease

    There is currently no reason to believe that most people with thyroid disease are at increased risk to contract this novel coronavirus or to experience complications. Nevertheless, if thyroid medications are not taken as prescribed, uncontrolled thyroid disease may increase a person’s risk for viral infection and complications.

  • New Updates to the AACE Diabetes Algorithm

    The AACE diabetes algorithm is a comprehensive management algorithm that covers lifestyle, obesity, prediabetes, lipids, hypertension and glucose management strategies.

  • AACE 2020 Election Results

    We are pleased to report to you the results of the AACE 2020 elections. Dr. Daniel L. Hurley, Chair of the Nominating Committee, thanks the members of the Nominating Committee for their time and effort evaluating a number of excellent candidates for Officer positions and the Board of Directors and for developing a strong slate of candidates for the 2020 election.

    we are aace
  • FDA approves additional doses of Trulicity® (dulaglutide) for the treatment of type 2 diabetes

    The U.S. Food and Drug Administration (FDA) approved two additional doses of Eli Lilly and Company's (NYSE: LLY) Trulicity® (dulaglutide). The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11. The phase 3 trial showed the additional doses led to further benefits in A1C and body weight reduction when compared to Trulicity 1.5 mg in people with type 2 diabetes.

  • AACE Position Statement: Coronavirus (COVID-19) and People with Diabetes

    As the coronavirus (COVID-19) continues to spread in the United States, it is important for every

  • Takeda Announces Recall of NATPARA (parathyroid hormone) for Injection

    Pharmaceutical company Takeda has announced the recall of the its parathyroid hormone for injection, NATPRA.

  • President/CEO Update to AACE Members – April 2020

    We continue to think of you during this unprecedented season. While over the last several weeks you have received many helpful pieces of guidance, research, and news updates - today we simply wish to remind you that our priority remains to be you: our members. You are the heart of AACE, and you are our foremost thought that guides anything and everything we do.

  • Video: AACE President Annual Address - May 2020

    Dr. Sandra Weber, AACE President 2019-2020, and Dr. Howard Lando, AACE President 2020-2021, deliver addresses to the American Association of Clinical Endocrinologists (AACE) community. Introduction by Paul Markowski, AACE CEO.

  • Video: Important AACE Member Update

    Drs. Leslie Eldeiry, Scott Isaacs, and Matthew Levine provide an important AACE member update on behalf of the Board of Directors on two upcoming changes regarding our brand and community. These will be further discussed at the Annual Business Meeting on September 11, 2020.

  • Introducing AACE Communities

    Coming soon: a new way to connect with your peers on a micro level

    aace communities
  • In Memoriam: Lewis E. Braverman, MD, MACE

    Lewis E. Braverman, MD, MACE, 89, passed away peacefully on Monday, June 10, 2019. He leaves his wife Mimi Braverman; his sons, William Braverman and Daniel Braverman; and his five grandchildren.

  • A Message to AACE Members Regarding CMS Proposed Rules

    Medicare imposed substantial cuts in reimbursements for the new and revised fine needle aspiration codes for 2019. AACE, together with the Endocrine Society and American Thyroid Association, advocated for you with letters to Centers for Medicare and Medicaid Services (CMS) and Congress opposing these cuts. We secured a win with the release of the proposed physician pay rule issued July 29. 

  • Severe Shortage of Treatments for Diabetes in Tigray, Ethiopia

    There is a severe shortage of diabetes medicines in the Tigray region of Ethiopia, jeopardizing thousands of persons with diabetes. We urge both government organizations and non-government organizations, including manufacturers to strive to improve access to life-saving treatments for diabetes in the Tigray region. Read our full statement to learn more.

    Severe Shortage of Treatments for Diabetes in Tigray, Ethiopia
  • Improvements in Excess Cortisol Activity With Relacorilant

    The investigational agent relacorilant significantly improved exces


I am proud to be an AACE member and to witness the continued growth of this organization.

Dr. Matthew Levine

Read More

One of our great strengths is our diversity: our growing AACE community represents a huge wealth and resource of people of diverse backgrounds.

Dr. Leslie Eldeiry

Read More

I am excited about our AACE and the place for clinical endocrinology in tomorrow’s health care ecosphere.

Dr. Sethu Reddy

Read More